Dr. Tenover is Vice President for Scientific Affairs at Cepheid, where he has worked since 2008.  He also serves as Consulting Professor of Pathology at Stanford University School of Medicine, Adjunct Professor of Epidemiology in the Rollins School of Public Health at Emory University, and Consulting Professor of Biology at the University of Dayton. Prior to joining Cepheid, he served for 18 years at the Centers for Disease Control and Prevention (CDC) in Atlanta as Associate Director for Laboratory Science in the Division of Healthcare Quality Promotion, where he directed the antimicrobial susceptibility testing laboratories, and the staphylococcal, anaerobe, and nosocomial gram-negative organism identification laboratories. His research team discovered the KPC carbapenem resistance gene and several other key resistance determinants. He then became the Director of the Office of Antimicrobial Resistance for CDC. Dr Tenover was a member of the CLSI Antimicrobial Susceptibility Testing Subcommittee for 17 years, developing novel test methods for resistance detection and interpretive criteria for new antimicrobial agents. At Cepheid, in addition to working on strategies for new product development and innovation, his research team focuses on rapid detection of healthcare-associated infections and mechanisms of carbapenem resistance. He is a Diplomate of the American Board of Medical Microbiology and a Fellow of both the American Academy of Microbiology and the Infectious Disease Society of America. He has authored over 330 peer-reviewed journal articles and has written or edited 11 books on microbiology and molecular diagnostics.